Stocks
176668SNTS
YHDHealthcareBiotechnology
A clinical-stage biopharmaceutical company developing therapies for rare diseases, with a focus on genetic disorders. Its lead programs target conditions with high unmet medical need, and investors track it for pipeline catalysts and regulatory milestones.
Congressional Interest in 176668 (SNTS)
1 member of Congress has disclosed 1 trade in 176668 (SNTS), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading SNTS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-04-08 | MICHAEL T. MCCAUL | buy | $1K-$15K |